0001116502-01-501248.txt : 20011030
0001116502-01-501248.hdr.sgml : 20011030
ACCESSION NUMBER: 0001116502-01-501248
CONFORMED SUBMISSION TYPE: 8-K/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20010705
ITEM INFORMATION: Financial statements and exhibits
FILED AS OF DATE: 20011026
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVAX CORP /DE
CENTRAL INDEX KEY: 0000772197
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 161003559
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 8-K/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09623
FILM NUMBER: 1768169
BUSINESS ADDRESS:
STREET 1: 4400 BISCAYNE BLVD
CITY: MIAMI
STATE: FL
ZIP: 33137
BUSINESS PHONE: 3055756000
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BOULEVARD
CITY: MIAMI
STATE: FL
ZIP: 33137
FORMER COMPANY:
FORMER CONFORMED NAME: INLAND VACUUM INDUSTRIES INC
DATE OF NAME CHANGE: 19870611
FORMER COMPANY:
FORMER CONFORMED NAME: IVACO INDUSTRIES INC
DATE OF NAME CHANGE: 19871213
FORMER COMPANY:
FORMER CONFORMED NAME: IVAX CORP
DATE OF NAME CHANGE: 19920703
8-K/A
1
ivax-8ka.txt
AMENDMENT NO. 1 TO FORM 8-K/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------
AMENDMENT 1
TO
FORM 8-K/A
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 5, 2001
IVAX CORPORATION
(Exact Name of Registrant as Specified in its Charter)
FLORIDA 1-09623 16-1003559
(State or Other Jurisdiction of Commission File Number) (IRS Employer
Incorporation) Identification No.)
4400 BISCAYNE BOULEVARD, MIAMI, FLORIDA 33137
(Address of Principal Executive Offices)
(305) 575-6000
(Registrant's Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed since Last Report)
-----------------------------------
This Amendment 1 to Form 8-K/A amends the Form 8-K filed with the
Commission on July 20, 2001 and the Form 8-K/A filed with the Commission on
August 1, 2001 relating to the acquisition by IVAX Corporation ("IVAX") of
Laboratorio Chile S.A. ("LabChile"). This Amendment 1 to Form 8-K/A is being
filed to amend the consent included as Exhibit 23.1 in the Form 8-K/A.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
The Exhibits to this Amendment 1 to Form 8-K/A are listed on the
Exhibit Index and are incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: October 26, 2001 IVAX CORPORATION
By: /s/ Thomas E. Beier
---------------------------------
Thomas E. Beier
Senior Vice President-Finance
Chief Financial Officer
2
Exhibit Index
Exhibit
Number Description
------ -----------
23.1 Consent of Arthur Andersen - Langton Clarke
EX-23.1
3
ex23-1.txt
CONSENT OF ARTUR ANDERSEN - LANGTON CLARKE
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
As independent accountants, we hereby consent to the incorporation by reference
in this Form 8-K/A and into IVAX' previously filed registration statements on
Form S-8 Nos. 333-30690, 333-30692, 333-07811, 33-82756, 33-67090, 33-39186,
33-44042, 33-53944, 33-88914, 33-88912, 33-65133, 333-24593, and 333-42997, Form
S-3 Nos. 33-46173, 333-43176 and 333-51372 and Form S-4 Nos. 33-44116, 33-60847
and 333-51364, of our reports dated June 20, 2001 and February 20, 2001, except
for Note 41 for which the date is June 20, 2001, included in the Laboratorio
Chile S.A. and subsidiaries (the "Company") Form 20-F for the year ended
December 31, 2000. It should be noted that we have not audited any financial
statements of the Company subsequent to December 31, 2000 or performed any audit
procedures subsequent to the date of our report.
ARTHUR ANDERSEN - LANGTON CLARKE
Santiago, Chile October 26, 2001